Position in BIOA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,321,682
+$507,245 QoQ
Shares Held
75,568
+22.8% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 87.90493330510269.ToString("F0")%
Shared 0.ToString("F0")%
None 12.09506669489731.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. BIOA ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,321,682 | 75,568 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $814,437 | 61,560 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $341,025 | 57,998 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $222,895 | 53,970 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $80,966 | 21,534 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $85,024 | 14,685 | Shares | Defined | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||